Literature DB >> 15598331

Mechanisms of autoimmune hepatitis.

Diego Vergani1, Giorgina Mieli-Vergani.   

Abstract

Autoimmune hepatitis (AIH) is a progressive inflammatory liver disease with a female preponderance, responsive to immunosuppressive treatment. Two types of AIH are described: type 1 AIH is characterized by positivity for smooth muscle and/or antinuclear antibody, while type 2 AIH is positive for liver kidney microsomal type 1 antibody. The putative mechanisms leading to the development of this condition include genetic predisposition to autoimmunity through possession of specific human leukocyte antigen alleles, immune reactions to liver cell antigens, possibly triggered by a mechanism of molecular mimicry, where immune responses to external pathogens, e.g. viruses, become directed toward structurally similar self-components, and an impairment in immune regulation. AIH has been described to arise de novo after liver transplantation. The mechanisms leading to post-transplant autoimmunity remain to be defined.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15598331     DOI: 10.1111/j.1399-3046.2004.00288.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  3 in total

1.  End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-gamma but is independent of Fas.

Authors:  Richard T Robinson; Jing Wang; James G Cripps; Michael W Milks; Kathryn A English; Todd A Pearson; James D Gorham
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

2.  Fulminant autoimmune hepatitis in a girl with 22q13 deletion syndrome: a previously unreported association.

Authors:  Maria Tufano; Claudia Della Corte; Francesco Cirillo; Maria Immacolata Spagnuolo; Manila Candusso; Daniela Melis; Giuliano Torre; Raffaele Iorio
Journal:  Eur J Pediatr       Date:  2008-05-14       Impact factor: 3.183

3.  Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study.

Authors:  Prodromos Hytiroglou; Julio A Gutierrez; Maria Freni; Joseph A Odin; Carmen M Stanca; Sukma Merati; Thomas D Schiano; Andrea D Branch; Swan N Thung
Journal:  Hepatol Res       Date:  2009-01-12       Impact factor: 4.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.